See also this year's filing and all EDGAR filings for this company.
PDF Report 0001653821_2021_CEN_BIOTECH_INC.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.020336698716020264, 'aggregate_val': 2543730, 'exp_sum': 2493030, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 1038466, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 1454564}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001653821')"} |
Graph
Absolute values for 0001653821, CEN BIOTECH INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 19,809 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,956,147 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,338,186 |
| 4 | LiabilitiesCurrent | 14,705,757 |
| 5 | LiabilitiesNoncurrent | 142,102 |
| 6 | remainder_Liabilities | 1,458,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,038,466 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 1,505,264 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 16,793,375 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 6,314,142 |
| 1 | Liabilities | 16,305,859 |
| 2 | Expenses | 2,543,730 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -9,991,717 |
| 5 | NetIncome | 14,249,645 |
| 6 | ComprehensiveNetIncome | 14,249,645 |
| 7 | BaseVar | 20,978,553 |
| 8 | EconomicCapitalRatio | -0.260 |
Edgar->Model Mapping
Feature Distribution
Change over Time
